Insulin Pen Buyers Can Name Sanofi's Puerto Rico Unit In Suit
Lantus insulin pen buyers can file a new antitrust class action against Sanofi-Aventis in order to name the drugmaker's Puerto Rico subsidiary as a defendant and two more companies as plaintiffs,...To view the full article, register now.
Already a subscriber? Click here to view full article